GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 126 filers reported holding GENOMIC HEALTH INC in Q1 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $10,906,000 | -48.3% | 318,887 | -51.4% | 0.95% | +4.7% |
| Q3 2017 | $21,076,000 | +96.5% | 656,786 | +99.3% | 0.91% | -4.1% |
| Q2 2017 | $10,728,000 | +15.5% | 329,585 | +11.7% | 0.94% | +4.1% |
| Q1 2017 | $9,288,000 | +33.1% | 294,962 | +24.3% | 0.91% | +10.7% |
| Q4 2016 | $6,976,000 | +9.0% | 237,371 | +7.2% | 0.82% | -1.6% |
| Q3 2016 | $6,402,000 | +19.8% | 221,354 | +7.3% | 0.83% | +6.9% |
| Q2 2016 | $5,342,000 | +16.8% | 206,291 | +11.8% | 0.78% | +8.0% |
| Q1 2016 | $4,572,000 | -27.3% | 184,586 | +3.3% | 0.72% | -30.7% |
| Q4 2015 | $6,293,000 | +24.5% | 178,769 | -25.1% | 1.04% | +23.6% |
| Q3 2015 | $5,053,000 | -9.8% | 238,797 | +18.5% | 0.84% | -3.4% |
| Q2 2015 | $5,599,000 | +13.3% | 201,490 | +24.5% | 0.87% | +12.7% |
| Q1 2015 | $4,943,000 | +2.5% | 161,796 | +7.2% | 0.77% | -5.5% |
| Q4 2014 | $4,824,000 | +53.2% | 150,896 | +35.6% | 0.82% | +23.9% |
| Q3 2014 | $3,149,000 | +15.3% | 111,244 | +11.6% | 0.66% | +21.3% |
| Q2 2014 | $2,731,000 | – | 99,669 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |